BLRX
BioLineRx Ltd
NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY
$2.79
-9.12% today
Updated 2026-04-30
Market cap
$10.21M
P/E ratio
0.00
P/S ratio
8.66x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $8
Volume
0.0M
BioLineRx Ltd (BLRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $16.27M | $31.89M | $63.91M | $113.16M | $113.16M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.80M | $28.94M | $1.19M |
| Revenue growth (YoY) | — | — | +96.0% | +100.4% | +77.1% | +0.0% | -100.0% | — | — | — | — | — | — | — | — | — | +502.9% | -95.9% |
| Cost of revenue | $636178.00 | $6.21M | $7.21M | $22.62M | $21.48M | $19.03M | $0.00 | $440893.00 | $481888.00 | $480675.00 | $451000.00 | $940000.00 | $934000.00 | $702000.00 | $654000.00 | $3.69M | $9.26M | $758973.00 |
| Gross profit | $-636178.00 | $10.07M | $24.69M | $-436813.00 | $-395182.00 | $-317771.00 | $-268366.00 | $-440893.00 | $-481888.00 | $-480675.00 | $-451000.00 | $-940000.00 | $-934000.00 | $-702000.00 | $-654000.00 | $1.11M | $19.68M | $430387.00 |
| Gross margin | — | 61.9% | 77.4% | -0.7% | -0.3% | -0.3% | — | — | — | — | — | — | — | — | — | 23.1% | 68.0% | 36.2% |
| R&D | $29.02M | $22.58M | $15.49M | $11.20M | $17.21M | $12.21M | $10.90M | $11.49M | $11.18M | $19.51M | $19.81M | $23.44M | $18.17M | $19.47M | $17.63M | $12.52M | $9.15M | $7.66M |
| SG&A | — | — | $4.14M | $3.34M | $3.71M | $3.68M | $3.49M | $3.65M | $3.95M | $4.04M | $4.41M | $3.74M | $3.84M | $4.27M | $5.07M | $16.64M | $18.46M | $3.92M |
| Operating income | $-33.29M | $-16.11M | $3.70M | $-16.37M | $-21.15M | $-17.01M | $-17.25M | $-16.20M | $-16.51M | $-25.24M | $-25.61M | $-28.11M | $-22.93M | $-24.78M | $-29.16M | $-49.69M | $-20.41M | $-10.37M |
| Operating margin | — | -99.0% | 11.6% | -25.6% | -18.7% | -15.0% | — | — | — | — | — | — | — | — | — | -1035.3% | -70.5% | -871.8% |
| EBITDA | $-31.42M | $-15.22M | $4.21M | $-15.00M | $-19.38M | $-16.69M | $-16.91M | $-15.77M | $-15.34M | $-24.80M | $-22.04M | $-22.65M | $-27.59M | $-24.07M | $-28.50M | $-57.09M | $3.92M | $-9.84M |
| EBITDA margin | — | -93.5% | 13.2% | -23.5% | -17.1% | -14.7% | — | — | — | — | — | — | — | — | — | -1189.3% | 13.5% | -827.5% |
| EBIT | $-32.06M | $-15.66M | $3.70M | $-15.41M | $-19.78M | $-17.02M | $-17.15M | $-16.21M | $-15.82M | $-25.24M | $-22.49M | $-23.59M | $-28.53M | $-24.78M | $-29.16M | $-58.47M | $-147000.00 | $-10.37M |
| Interest expense | — | — | $16629.00 | $1.12M | $25964.00 | $20674.00 | $411666.00 | $15000.00 | $14000.00 | $21000.00 | $21000.00 | $1.83M | $1.47M | $984000.00 | $2.16M | $2.17M | $9.16M | $1.29M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-32.06M | $-15.66M | $2.10M | $-13.19M | $-20.42M | $-17.64M | $-10.17M | $-14.40M | $-15.84M | $-24.35M | $-22.96M | $-25.45M | $-30.02M | $-27.05M | $-24.95M | $-60.61M | $-9.22M | $-1.18M |
| Net income growth (YoY) | — | +51.1% | +113.4% | -728.8% | -54.8% | +13.6% | +42.3% | -41.5% | -10.0% | -53.7% | +5.7% | -10.8% | -18.0% | +9.9% | +7.8% | -142.9% | +84.8% | +87.2% |
| Profit margin | — | -96.3% | 6.6% | -20.6% | -18.0% | -15.6% | — | — | — | — | — | — | — | — | — | -1262.8% | -31.9% | -99.6% |